Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Dallas, Texas

CNS trials open to children and teens in Dallas, TX

9 CNS studies open to children and teens are recruiting participants at sites in Dallas as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Dallas at a glance

  • 9 studies are recruiting at a site in Dallas.
  • By phase: Phase 1/2 (2), Phase 3 (4), No phase (2), Observational (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (5), industry (4).
  • By research area: Depression (3), Migraine (3), Epilepsy (2), ADHD (1).
  • Most recent update to one of these records: November 18, 2026.

ADHD studies recruiting in Dallas

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Pediatric Epilepsy

    • No phase
    • Ages 3 to 25
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Study site
    Children's Medical Center Dallas
    Registry record
    NCT07350551 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Dallas, TX on ClinicalTrials.gov.

Depression studies recruiting in Dallas

  1. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Relaro Medical Trials /ID# 227156
    Registry record
    NCT04777357 · updated
  2. Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression

    • Observational
    • Ages 12 to 18
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Study site
    Child and adolescent psychiatrist at the Children's Health Psychiatry Clinic.
    Registry record
    NCT07430774 · updated
  3. Teen Recovery Through Inspiration, Support, and Empowerment

    • No phase
    • Ages 15 to 18
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Study site
    The University of Texas Southwestern Medical Center
    Registry record
    NCT07170657 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Dallas, TX on ClinicalTrials.gov.

Epilepsy studies recruiting in Dallas

  1. Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder

    • Phase 1/2
    • Ages 2 to 20
    • All sexes
    Sponsor
    TESS Research Foundation
    Study site
    University of Texas Southwestern Medical Center
    Registry record
    NCT07102524 · updated
  2. A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease

    • Phase 1/2
    • Ages 10 to 18
    • All sexes
    Sponsor
    Berge Minassian
    Study site
    Childrens Health
    Registry record
    NCT06609889 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Dallas, TX on ClinicalTrials.gov.

Migraine studies recruiting in Dallas

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    FutureSearch Trials of Dallas, LLC
    Registry record
    NCT04649242 · updated
  2. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Alina Clinical Trials, LLC.
    Registry record
    NCT05156398 · updated
  3. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study sites
    Cedar Health Research /ID# 228003 · Relaro Medical Trials /ID# 239642
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Dallas, TX on ClinicalTrials.gov.

Ask about studies near Dallas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Texas

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call